Literature DB >> 10516295

Generation and analysis of GluR5(Q636R) kainate receptor mutant mice.

A Sailer1, G T Swanson, I Pérez-Otaño, L O'Leary, S A Malkmus, R H Dyck, H Dickinson-Anson, H H Schiffer, C Maron, T L Yaksh, F H Gage, S O'Gorman, S F Heinemann.   

Abstract

The physiological significance of RNA editing of transcripts that code for kainate-preferring glutamate receptor subunits is unknown, despite the fact that the functional consequences of this molecular modification have been well characterized in cloned receptor subunits. RNA editing of the codon that encodes the glutamine/arginine (Q/R) site in the second membrane domain (MD2) of glutamate receptor 5 (GluR5) and GluR6 kainate receptor subunits produces receptors with reduced calcium permeabilities and single-channel conductances. Approximately 50% of the GluR5 subunit transcripts from adult rat brain are edited at the Q/R site in MD2. To address the role of glutamate receptor mRNA editing in the brain, we have made two strains of mice with mutations at amino acid 636, the Q/R-editing site in GluR5, using embryonic stem cell-mediated transgenesis. GluR5(RloxP/RloxP) mice encode an arginine at the Q/R site of the GluR5 subunit, whereas GluR5(wt(loxP)/wt(loxP)) mice encode a glutamine at this site, similar to wild-type mice. Mutant animals do not exhibit developmental abnormalities, nor do they show deficits in the behavioral paradigms tested in this study. Kainate receptor current densities were reduced by a factor of six in acutely isolated sensory neurons of dorsal root ganglia from GluR5(RloxP/RloxP) mice compared with neurons from wild-type mice. However, the editing mutant mice did not exhibit altered responses to thermal and chemical pain stimuli. Our investigations with the GluR5-editing mutant mice have therefore defined a set of physiological processes in which editing of the GluR5 subunit is unlikely to play an important role.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516295      PMCID: PMC6782774     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  18 in total

1.  Loss of kainate receptor-mediated heterosynaptic facilitation of mossy-fiber synapses in KA2-/- mice.

Authors:  Anis Contractor; Andreas W Sailer; Melanie Darstein; Cornelia Maron; Jian Xu; Geoffrey T Swanson; Stephen F Heinemann
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

2.  Explaining Pathogenicity of Congenital Zika and Guillain-Barré Syndromes: Does Dysregulation of RNA Editing Play a Role?

Authors:  Helen Piontkivska; Noel-Marie Plonski; Michael M Miyamoto; Marta L Wayne
Journal:  Bioessays       Date:  2019-05-20       Impact factor: 4.345

Review 3.  A-to-I RNA editing - immune protector and transcriptome diversifier.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Nat Rev Genet       Date:  2018-08       Impact factor: 53.242

Review 4.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

Review 5.  Editing of neurotransmitter receptor and ion channel RNAs in the nervous system.

Authors:  Jennifer L Hood; Ronald B Emeson
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  Kainate receptors expressed by a subpopulation of developing nociceptors rapidly switch from high to low Ca2+ permeability.

Authors:  C J Lee; H Kong; M C Manzini; C Albuquerque; M V Chao; A B MacDermott
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

7.  Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance.

Authors:  Johanna J Bogulavsky; Ann M Gregus; Paul T-H Kim; Alberto C S Costa; Anjali M Rajadhyaksha; Charles E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  2008-10-28       Impact factor: 4.030

Review 8.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

9.  ADAR1 and ADAR2 expression and editing activity during forebrain development.

Authors:  Michelle M Jacobs; Rachel L Fogg; Ronald B Emeson; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-03-27       Impact factor: 2.984

10.  GluK2-mediated excitability within the superficial layers of the entorhinal cortex.

Authors:  Prateep S Beed; Benedikt Salmen; Dietmar Schmitz
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.